PlainRecalls
FDA Drug Low Class III Terminated

Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81

Reported: January 25, 2017 Initiated: December 2, 2016 #D-0432-2017

Product Description

Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81

Reason for Recall

Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

Details

Recalling Firm
Shire PLC
Units Affected
4,520 bottles
Distribution
Nationwide and Puerto Rico
Location
Lexington, MA

Frequently Asked Questions

What product was recalled?
Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81. Recalled by Shire PLC. Units affected: 4,520 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2017. Severity: Low. Recall number: D-0432-2017.